EVNIN LUKE — SEC Form 4 filings
SEC reporting owner CIK 1134657. 41 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2024-05-24 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,112,777 shares, $20,029,986 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 103 legs across 38 filings — 5,483,145 shares, $12,855,025 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 1,112,777 shares @ $18.00 ($20,029,986) in Aktis Oncology, Inc., filed 2026-01-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aktis Oncology, Inc. (AKTS) | 10% owner | 1 | 1 leg · 1,112,777 sh · $20,029,986 | — | 6 |
| iTeos Therapeutics, Inc. (ITOS) | — | 1 | — | 1 leg · 630,191 sh · $5,079,339 | — |
| Entrada Therapeutics, Inc. (TRDA) | 10% owner | 5 | — | 14 legs · 540,669 sh · $4,517,581 | — |
| Werewolf Therapeutics, Inc. (HOWL) | Director | 34 | — | 88 legs · 4,312,285 sh · $3,258,105 | 5 |
Form 4 filings — EVNIN LUKE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 38,500 @ $7.11 · Sale (S): 192,500 @ $7.41 · Sale (S): 28,837 @ $7.13 | EDGAR |
| 2026-09-03 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 29,088 @ $7.06 · Sale (S): 25,131 @ $7.19 · Sale (S): 32,263 @ $7.17 | EDGAR |
| 2026-08-31 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 38,922 @ $7.20 · Sale (S): 3,733 @ $7.01 · Sale (S): 44,259 @ $6.99 | EDGAR |
| 2026-08-26 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 21,623 @ $7.34 · Sale (S): 26,522 @ $7.54 · Sale (S): 14,569 @ $7.06 | EDGAR |
| 2026-07-08 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 35,770 @ $0.32 · Sale (S): 107,429 @ $0.31 | EDGAR |
| 2026-06-29 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 157,084 @ $0.30 | EDGAR |
| 2026-06-10 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 76,928 @ $0.37 | EDGAR |
| 2026-06-08 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 20,072 @ $0.44 · Sale (S): 24,946 @ $0.40 · Sale (S): 60,547 @ $0.40 | EDGAR |
| 2026-06-03 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 80,459 @ $0.47 · Sale (S): 29,595 @ $0.45 · Sale (S): 29,749 @ $0.42 | EDGAR |
| 2026-05-29 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 80,852 @ $0.48 · Sale (S): 27,698 @ $0.46 · Sale (S): 32,556 @ $0.45 | EDGAR |
| 2026-05-26 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 36,387 @ $0.42 · Sale (S): 87,425 @ $0.45 · Sale (S): 67,950 @ $0.47 | EDGAR |
| 2026-05-20 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 22,184 @ $0.50 · Sale (S): 62,970 @ $0.45 · Sale (S): 85,895 @ $0.43 | EDGAR |
| 2026-05-13 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 44,679 @ $0.54 | EDGAR |
| 2026-05-12 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 305,741 @ $0.70 · Sale (S): 33,948 @ $0.67 · Sale (S): 67,885 @ $0.64 | EDGAR |
| 2026-05-07 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 6,860 @ $0.69 · Sale (S): 14,635 @ $0.66 · Sale (S): 79,086 @ $0.63 | EDGAR |
| 2026-05-04 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 168,262 @ $0.72 · Sale (S): 58,394 @ $0.73 · Sale (S): 47,963 @ $0.72 | EDGAR |
| 2026-04-29 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 53,940 @ $0.85 · Sale (S): 95,412 @ $0.73 · Sale (S): 56,559 @ $0.69 | EDGAR |
| 2026-01-20 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 38,782 @ $0.54 | EDGAR |
| 2026-01-15 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 43,198 @ $0.55 · Sale (S): 30,616 @ $0.57 · Sale (S): 37,413 @ $0.55 | EDGAR |
| 2026-01-14 | 4 | Aktis Oncology, Inc. (AKTS) jointly with MPM BIOVENTURES 2018, L.P., MPM BIOVENTURES 2018 (B), L.P., MPM BioVentures 2018 LLC, MPM BioVentures 2018 GP LLC, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM ONCOLOGY INNOVATIONS FUND LP, MPM Oncology Innovations Fund GP LLC | Conversion (C): 1,314,262 · Conversion (C): 5,914,197 · Conversion (C): 1,577,119 · Purchase (P): 1,112,777 @ $18 · Conversion (C): 5,000,000 (derivative) @ $0 · Conversion (C): 22,500,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-12 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 7,716 @ $0.63 · Sale (S): 24,678 @ $0.61 · Sale (S): 58,980 @ $0.57 | EDGAR |
| 2026-01-07 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 18,378 @ $0.64 · Sale (S): 40,761 @ $0.65 · Sale (S): 11,915 @ $0.64 | EDGAR |
| 2026-01-02 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 34,847 @ $0.61 · Sale (S): 24,962 @ $0.62 · Sale (S): 18,568 @ $0.63 | EDGAR |
| 2025-12-29 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 59,307 @ $0.69 · Sale (S): 71,428 @ $0.63 · Sale (S): 16,310 @ $0.65 · Sale (S): 35,632 @ $0.63 · Sale (S): 108,606 @ $0.61 | EDGAR |
| 2025-12-17 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 23,640 @ $1.07 · Sale (S): 14,548 @ $1.05 · Sale (S): 9,983 @ $1.14 | EDGAR |
| 2025-12-12 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 37,104 @ $1.06 · Sale (S): 28,009 @ $1.07 · Sale (S): 17,858 @ $1.08 | EDGAR |
| 2025-12-09 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 16,568 @ $0.97 · Sale (S): 34,041 @ $0.99 · Sale (S): 44,570 @ $1.01 | EDGAR |
| 2025-12-04 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 38,043 @ $0.89 · Sale (S): 36,726 @ $0.87 · Sale (S): 53,416 @ $0.97 | EDGAR |
| 2025-12-01 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 38,978 @ $0.98 · Sale (S): 13,014 @ $0.99 · Sale (S): 39,096 @ $0.94 | EDGAR |
| 2025-11-25 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 41,287 @ $0.83 · Sale (S): 56,992 @ $0.98 · Sale (S): 27,297 @ $0.92 | EDGAR |
| 2025-11-20 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 33,776 @ $0.93 · Sale (S): 42,566 @ $0.94 · Sale (S): 26,411 @ $0.89 | EDGAR |
| 2025-11-17 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 58,372 @ $0.98 · Sale (S): 39,560 @ $0.93 · Sale (S): 36,621 @ $0.95 | EDGAR |
| 2025-11-12 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 43,950 @ $1.11 · Sale (S): 31,172 @ $1.18 · Sale (S): 35,818 @ $1.14 · Sale (S): 26,101 @ $1.09 | EDGAR |
| 2025-11-06 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 90,164 @ $1.22 · Sale (S): 30,774 @ $1.22 · Sale (S): 34,947 @ $1.21 | EDGAR |
| 2025-11-03 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 55,795 @ $1.43 · Sale (S): 73,192 @ $1.28 · Sale (S): 60,369 @ $1.29 | EDGAR |
| 2025-10-29 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Sale (S): 46,664 @ $1.72 · Sale (S): 44,327 @ $1.64 · Sale (S): 86,154 @ $1.55 | EDGAR |
| 2025-06-13 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, Foley Todd | Sale (S): 630,191 @ $8.06 | EDGAR |
| 2025-04-30 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Option exercise/expiry (X): 28,113 @ $0.09 · Sale (S): 2,425 @ $1.05 · Option exercise/expiry (X): 4,015 (derivative) @ $0 · Option exercise/expiry (X): 24,098 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with MPM BioVentures 2014, L.P., GADICKE ANSBERT, Foley Todd, MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014 GP LLC, MPM BIOVENTURES 2018 (B), L.P., MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Sale (S): 22,935 @ $20.77 · Sale (S): 21,787 @ $20.23 | EDGAR |
| 2024-05-24 | 4 | Werewolf Therapeutics, Inc. (HOWL) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1134657 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →